PROM1 and glioblastoma: CD133 has been used to isolate populations of cancer stem cells with enhanced stem cell phenotypes from multiple types of brain cancer and these CD133+ cells from glioblastoma are capable of multi-lineage differentiation and had a high capacity for neurosphere formation (15,16).